COVID-19 and Advances in Reproductive Toxicology Assessment

Dear Colleagues,

It is a great pleasure to invite all researchers within the field of human and comparative reprotoxicology to submit their work for publication in the Special Issue entitled: “COVID-19 and Advances in Reproductive Toxicology Assessment”.

As is commonly known, the exposure of an individual to different chemicals can result in serious consequences to the health of the individual in question. The derived toxicity of free radical overexpression, and the genotoxic effects in somatic and germinal cells can lead to the development of several genetic disorders and infertility. Many recent studies have demonstrated that drug treatments and plastics exert significant endocrine-disrupting effects on organisms, interfering with the normal physiological functions of the reproductive and nervous systems via related signaling pathways. Furthermore, the strategy used worldwide to combat the COVID-19 pandemic involves both behavioral—using disposable face masks—and pharmacological interventions. Therefore, the need for a better understanding of the molecular mechanisms related with oxidative stress, genotoxicity, DNA methylation and their regulation in reprotoxicity is significant. This will help us to understand the potential damage and how to develop potential therapeutic and preventive approaches that will be useful in protecting resources and life sustainability.

We are looking for advanced experimental and computational studies in the form of original articles, review articles and short communications to be included in this Special Issue. Fields of interest for this publication include—but are not limited to— quantitative metagenomics profiling, multi-omics approaches, identification of new potential nutraceuticals to fight COVID-19 reprotoxicity. We encourage researchers working on topics related to these to consider submitting their work for publication.

Prof. Dr. Giulia Guerriero
Dr. Kamla Kant Shukla
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Reproductive Medicine is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.